Skip to main content
Premium Trial:

Request an Annual Quote

Imagene Labs, Kalbe Partner for Genetic Risk Tests

NEW YORK – Indonesian healthcare provider Kalbe and Singaporean genome analysis firm Imagene Labs said last Friday that they have partnered to develop genetic risk tests.

Kalbe is launching two new DNA tests that employ patented ancestry-based genetic risk scoring technology developed by Imagene Labs. The PrimeGenme test analyzes more than 1,800 genetic variants related to longevity and healthy aging, while the KiddyGenme test looks at more than 300 genes to provide “insights into a child’s innate talents and personality,” the companies said.

The tests will be commercially available to consumers through Kalbe’s e-commerce site and its network of hospital and clinic partners, according to the firms.

Last year, Imagene Labs struck a partnership with Invenio Genetics in California to develop an improved fitness and nutrition consumer genomics test.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.